XM does not provide services to residents of the United States of America.
A
A

ArthurJGallagher

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

U.S. Darden Restaurants, FedEx, Nike

U.S. RESEARCH ROUNDUP-Darden Restaurants, FedEx, Nike March 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Darden Restaurants, Fedex and Nike on Friday. HIGHLIGHTS * Darden Restaurants DRI.N : JP Morgan cuts PT to $176 from $180 * FedEx Corp FDX.N : Baird raises target price to $325 from $315 * Nike NKE.N : Jefferies cuts target price to $100 from $110 * Penumbra PEN.N : Truist Securities cuts target price to $28
A
C
G
N
X
A
C
C
D
M

Arthur J. Gallagher & Co. Enters Into Equity Distribution Agreement On March 14

BRIEF-Arthur J. Gallagher & Co. Enters Into Equity Distribution Agreement On March 14 March 14 (Reuters) - Arthur J Gallagher & Co AJG.N : ARTHUR J. GALLAGHER & CO. - ON MARCH 14 ENTERED INTO AN EQUITY DISTRIBUTION AGREEMENT ARTHUR J. GALLAGHER & CO. - PURSUANT TO AGREEMENT MAY OFFER AND SELL UP TO 3 MILLION SHARES OF COMPANY'S COMMON STOCK IN "AT--MARKET" OFFERINGS ARTHUR J.
A

Australia's PSC Insurance says in buyout talks

UPDATE 1-Australia's PSC Insurance says in buyout talks Adds details from paragraph 2 onwards March 13 (Reuters) - Australia's PSC Insurance PSI.AX said on Wednesday it is in talks regarding a possible buyout after being approached by multiple parties, confirming a local media report. The Australian Financial Review (AFR) reported on Tuesday that the insurer has held informal discussions with at least two offshore brokers and hired Goldman Sachs to handle preliminary talks.
A

Ship evacuated after first civilian fatalities in Houthis' Red Sea attacks

WRAPUP 2-Ship evacuated after first civilian fatalities in Houthis' Red Sea attacks Adds comment on salvage efforts, insurance, Vietnam response Three killed in Houthi attack on ship in Red Sea Indian navy takes 20 crew members to Djibouti Two crew members seriously injured Maritime organisations call for more protection By Jonathan Saul LONDON, March 7 (Reuters) - India's navy evacuated all 20 crew from a stricken vessel in the Red Sea on Thursday, after a Houthi attack killed three seafarers i
A

U.S. Bruker, Cymabay Therapeutics, SSR Mining

U.S. RESEARCH ROUNDUP-Bruker, Cymabay Therapeutics, SSR Mining Feb 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Bruker, Cymabay Therapeutics and SSR Mining, on Wednesday. HIGHLIGHTS * Bruker Corp BRKR.O : JP Morgan raises to overweight from neutral * Cymabay Therapeutics Inc CBAY.O : Piper Sandler cuts to neutral from overweight * HP Inc HPQ.N : HSBC raises to buy from hold * SSR Mining Inc SSRM.O : CIBC cuts t
A
A
B
C
C
H
I
M
P
S
C
E
L
A
A
C
C
H
M

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.